|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
National Center for Complementary and Alternative Medicine (NCCAM) National Institute of Neurological Disorders and Stroke (NINDS) |
| Information provided by: | National Center for Complementary and Alternative Medicine (NCCAM) |
| ClinicalTrials.gov Identifier: | NCT00065754 |
Purpose
This study examines the mechanisms, including brain imaging of placebo analgesia
| Condition | Intervention |
|
Irritable Bowel Syndrome |
Drug: placebo |
| Study Type: | Interventional |
| Study Design: | Educational/Counseling/Training, Randomized, Double-Blind, Factorial Assignment |
| Official Title: | Brain Imaging and Pain: Analysis of Placebo Analgesia |
Eligibility
| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion criteria:
Exclusion criteria:
Contacts and Locations| United States, Florida | |||||
| University of Florida | |||||
| Gainesville, Florida, United States, 32610 | |||||
| National Center for Complementary and Alternative Medicine (NCCAM) |
| National Institute of Neurological Disorders and Stroke (NINDS) |
| Principal Investigator: | Michael E Robinson, PhD | University of Florida |
More Information
| Study ID Numbers: | R01 AT001424-01 |
| First Received: | July 31, 2003 |
| Last Updated: | April 11, 2007 |
| ClinicalTrials.gov Identifier: | NCT00065754 |
| Health Authority: | United States: Federal Government |
|
|
|
|